Targeting mitochondrial problems eases cholestasis in mice
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
Health Canada has authorized a point-of-care test that may be used to quickly diagnose hepatitis C and monitor treatment response.| Liver Disease News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
Rezdiffra has become the first approved therapy for some people with severe fatty liver disease in the European Union.| Liver Disease News
The FDA has conditionally approved Wegovy (semaglutide) to treat certain people with a serious form of fatty liver disease.| Liver Disease News
Hepatitis B treatment needs a global overhaul to meet the WHO’s goal of eliminating the virus as a public health threat by 2030, per a study.| Liver Disease News
Columnist Kathryn Hudson has been tempted to seek advice from "Dr. Google," but she knows it's a poor substitute for a medical professional.| Liver Disease News
The American Liver Foundation's 2025 Liver Life Walk spotlights Domenic Frappolli of Dallas, who was born with biliary atresia.| Liver Disease News
